Company
Products
Clinical Trials
Investors & Media
Careers

Startseite › Clinical Trials

Clinical Trials

Products

For more information about our epigenetic products please visit

Publications / Presentations / Posters

11. Jan 2023

European Medicines Agency Accepts 4SC’s Eligibility Request for Resminostat in Cutaneous T cell Lymphoma (CTCL)

14. Nov 2022

Kathleen Masch-Wiest is new Member of the Management Board of 4SC

18. Oct 2022

4SC provides Q3 highlights and financial forecast

Share this page:

Follow us on:

© 2023 - 4SC AG Seite drucken

Imprint
Privacy Policy
Contact